Christoph Bruening

Christoph Bruening is a declared insider of Callisto Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 8 January 2010 to 19 January 2010, the count stands at 7 filings.

No open-market purchase appears, only 7 sales worth €16k.

Most recently, on 20 January 2010, the filings show an open-market sale worth €749 in Callisto Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 9 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.